Abstract:
We report the promising urease inhibitory activity of four sets of tetrahydro thiadiazine thiones (THTT)
namely 3,5-disubstituted tetrahydro-2H-1,3,5-thiadiazine thiones: THTT 5˗8 (set A) having alkyl/aryl substituents at N-3 and N-5 positions; THTT 9˗12 (set B) and THTT 13˗14 (set C) with 3-carboxylic acid derivatives and tetrahydro-2H1,3,5-thiadiazine-6-thione esters 15˗16 (set D). Gratifyingly, all four sets of THTT were recognized as promising inhibitors of urease enzyme. Among 12 tested compounds; THTT 6, 8, 10, 14 and 15 from each set respectively, demonstrated significant urease inhibitory activity with IC50 values between 11.2˗29.8 μM which is mostly found higher than that for thiourea, a standard urease inhibitor with IC50 value of 22.4 μM. Furthermore, compound 7 showed almost the same level of inhibition (IC50 = 22.5 μM) as of standard. In addition, molecular docking study supported the phenomenon that thiadiazinane ring itself is an active pharmacophore that binds through CH2 groups and S atom via carbon-hydrogen/π-sulfur interactions respectively to the active site of the urease enzyme. The optimistic results from this study suggest the use of thiadiazinane skeleton as a guided template for the advancement of new urease inhibitors in drug discovery.
